Rare Disease Day: Uniting Compassion, Data, and Global Action for Accessible Healthcare
What rare disease day means for our work at SAI Every leap year, on the 29th of February, the world […]
Company
SAI MedPartners Expands Strategic Investments: Driving Growth and Elevating Consultancy Excellence
In the dynamic world of pharmaceutical services, strategic investments play a vital role in shaping the future of organizations. We are happy to announce that we have recently made headlines with our strategic acquisitions of Fulcrum Research Group (FRG) and Pharmaforce International (PFI). To shed light on the motivations behind these investments and the vision driving SAI MedPartners forward, we had the privilege of sitting down with the company’s CEO, Erik Nordhoy.
SAI MedPartners takes on strategic investment from Northlane Capital
Our CEO Erik Nordhoy talks about the new partnership SAI MedPartners has recently taken on a strategic investment from Northlane